InvestmentJun 15, 2026, 08:31 AM
Splash Beverage Group Invests CDN$300,000 in Avicanna Inc.
AI Summary
Splash Beverage Group announced the completion of a CDN$300,000 strategic investment in Avicanna Inc., a commercial-stage cannabinoid-based biopharmaceutical company. This move aligns with Splash's previously stated transformation into a cannabinoid-based health, wellness, and healthcare-focused platform. Splash acquired 2,000,000 common shares and 1,000,000 warrants in Avicanna, citing its sophisticated platform, intellectual property, and operational execution as key differentiators for the evolving medical cannabinoid market.
Key Highlights
- Splash Beverage Group completed a CDN$300,000 strategic investment in Avicanna Inc.
- The investment involved acquiring 2,000,000 common shares of Avicanna.
- Splash also acquired 1,000,000 warrants in Avicanna.
- This aligns with Splash's transformation into a cannabinoid-focused platform company.
- Avicanna's portfolio includes Trunerox", a CBD treatment for severe epilepsy.
- Avicanna operates MyMedi.ca, a leading medical cannabis care platform in Canada.
Price Impact
More from SBEV